The Turkish Medicines and Medical Devices Agency (“TITCK“) recently announced the results of its market surveillance and inspection of the cosmetics sector conducted in January, February and March 2022.
Of the 397 cosmetic products inspected by the TİTCK Cosmetics Supervision Department, 132 were non-compliant and 2 were unsafe. A total fine of 350,000 TRY (about 24,000 USD) was imposed on the companies responsible.
Of the 27 Type 1 and Type 19 biocidal products inspected by TİTCK’s Cosmetic Control Department, 4 were non-compliant and 16 were not authorized. A total fine of 537,920 TRY (approximately 36,886 USD) was imposed on the companies responsible.
What do the results say?
The safety results for cosmetic products reveal a significant reduction in the number of products checked and non-compliant products. On the other hand, the total amount of administrative fines increased compared to the results of the fourth quarter of 2021.
Safety results for type 1 and type 19 biocidal products show a decrease in the number of products checked, unlicensed and non-compliant. As a result, there is also a significant decrease in the total amount of administrative fines.
Q1 2022 results for Cosmetics are available here (in Turkish). Q1 2022 results of Type 1 and Type 19 biocidal products are available here (in Turkish).
TİTCK continues to demonstrate its commitment to the periodic monitoring and inspection of the cosmetics and biocidal products market. All cosmetic and biocidal products in circulation must fully comply with applicable Turkish laws and regulations, and manufacturing companies must ensure that they do not sell or distribute unsafe, unlicensed or non-compliant products.
The content is provided for educational and informational purposes only and is not intended and should not be construed as legal advice. This may qualify as “lawyer advertising” requiring notice in some jurisdictions. Prior results do not guarantee similar results. For more information, please visit: www.bakermckenzie.com/en/disclaimers.